Synapse - Works

Results (4073)

Long-term safety and efficacy analysis of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (COU-AA-302)

Meeting Abstract

Rathkopf, D. E.; Smith, M. R.; De Bono, J. S.; Logothetis, C.; Shore, N.; De Souza, P. L.; Fizazi, K.; Mulders, P.; Mainwaring, P. N.; Hainsworth, J. D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Results after long-term follow-up from the CAN2007 phase I/II study of weekly or twice-weekly bortezomib in patients (pts) with relapsed systemic light-chain (AL) amyloidosis

Meeting Abstract

Reece, D. E.; Hegenbart, U.; Sanchorawala, V.; Merlini, G.; Palladini, G.; Blade, J.; Fermand, J. P.; Hassoun, H.; Heffner, L.; Pei, L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Needs assessment and utilization of an educational workshop and support group for Lynch syndrome patients

Meeting Abstract

Rau-Murthy, R.; Anrig, C.; Glogowski, E.; Salo-Mullen, E. E.; Fleischut, M. H.; Sarrel, K.; Corines, M.; Niehaus, K.; Robson, M. E.; Markowitz, A.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A validated 34-gene signature for assessing risk of recurrence in clear cell renal cell carcinoma

Meeting Abstract

Rathmell, K.; Brooks, S. A.; Brannon, A. R.; Parker, J. S.; Fisher, J. C.; Sen, O.; Nielsen, M. E.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Preliminary HER2 expression data from NeuACT, the phase II randomized, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Hoffman-Censits, J. H.; Quinn, D. I.; Sharma, P.; DeVries, T.; Chen, M.; Locker, M.; Bajorin, D. F.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Differences in psychosocial factors among diverse women enrolled in a phase III cooperative group metastatic breast cancer trial (CALGB 40502/Alliance)

Meeting Abstract

Polite, B. N.; Allred, J. B.; Rugo, H. S.; Cipriano, T. M.; Cirrincione, C.; Gehlert, S. J.; Paskett, E. D.; Hudis, C.; Winer, E. P.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Interim results of phase II study BRF113928 of dabrafenib in BRAF V600E mutation-positive non-small cell lung cancer (NSCLC) patients

Meeting Abstract

Planchard, D.; Mazieres, J.; Riely, G. J.; Rudin, C. M.; Barlesi, F.; Quoix, E. A.; Souquet, P. J.; Socinski, M. A.; Switzky, J.; Ma, B.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Infectious disease associations in advanced stage, indolent lymphoma (follicular, FL, and nonfollicular, nFL): A prospective trial of antibiotic therapy

Meeting Abstract

Portlock, C. S.; Hamlin, P. A.; Gerecitano, J. F.; Noy, A.; Palomba, M. L.; Walkley, J.; Corcoran, S.; Papanicolaou, G. A.; Markowitz, A.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase II study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy in patients with muscle-invasive urothelial cancer (MI-UC): Pathologic and radiologic response, serum tumor markers, and DNA excision repair pathway biomarkers in relation to disease-free survival (DFS)

Meeting Abstract

Qu, A. Q.; Jacobus, S. J.; Signoretti, S.; Stack, E. C.; Krajewski, K. M.; Rosenberg, J. E.; Choueiri, T. K.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Pharmacodynamic effect of ipilimumab on absolute lymphocyte count (ALC) and association with overall survival in patients with advanced melanoma

Meeting Abstract

Postow, M. A.; Chasalow, S. D.; Yuan, J.; Kuk, D.; Panageas, K. S.; Cheng, M.; Shahabi, V.; Berman, D. M.; Wolchok, J. D.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save